Found: 12
Select item for more details and to access through your institution.
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2016, v. 18, n. 3, p. 138, doi. 10.7224/1537-2073.2015-020
- By:
- Publication type:
- Article
Guillain-Barré Syndrome Incidence in a Large United States Cohort (2000-2009).
- Published in:
- Neuroepidemiology, 2012, v. 39, n. 2, p. 109, doi. 10.1159/000339248
- By:
- Publication type:
- Article
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 8, p. 1025, doi. 10.1177/1352458514557986
- By:
- Publication type:
- Article
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing–remitting multiple sclerosis: findings from the CONFIRM study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 253, doi. 10.1177/1352458513507818
- By:
- Publication type:
- Article
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: The DEFINE study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 243, doi. 10.1177/1352458513507817
- By:
- Publication type:
- Article
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 2, p. 103, doi. 10.1002/acn3.148
- By:
- Publication type:
- Article
A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of Potential Drug–Drug Interaction Between Delayed‐Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 604, doi. 10.1002/cpdd.377
- By:
- Publication type:
- Article
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsingremitting multiple sclerosis.
- Published in:
- BMC Neurology, 2014, v. 14, n. 1, p. 7, doi. 10.1186/s12883-014-0240-x
- By:
- Publication type:
- Article
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Risk of Confirmed Guillain-Barré Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009–2010.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Risk of Confirmed Guillain-Barré Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009–2010.
- Published in:
- American Journal of Epidemiology, 2012, v. 175, n. 11, p. 1100, doi. 10.1093/aje/kws195
- By:
- Publication type:
- Article